HETERO LABS LTD INDIA

HETERO LABS LTD INDIA is primarily a manufacturer (factory).

Company Introduction:

Hetero Labs Ltd. is one of India's largest generic pharmaceutical companies and a leading global producer of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). Headquartered in Hyderabad, India, Hetero is a vertically integrated pharmaceutical organization with a strong focus on research and development, manufacturing, and marketing of a wide range of products across diverse therapeutic categories including antiretrovirals, oncology, cardiovascular, neurology, urology, diabetes, and dermatology. The company operates numerous state-of-the-art manufacturing facilities approved by various international regulatory bodies. Hetero is recognized for its significant contributions to making essential medicines accessible and affordable worldwide.

Hetero Labs Ltd India manufactures and sells a comprehensive range of pharmaceutical products, including Active Pharmaceutical Ingredients APIs and finished dosage formulations across numerous therapeutic categories.

Their product portfolio includes:

Antiretrovirals for HIV AIDS treatment, such as Tenofovir, Efavirenz, Lamivudine, Dolutegravir, Ritonavir, and Lopinavir.

Oncology products, including Imatinib, Dasatinib, Nilotinib, Erlotinib, Gefitinib, Sorafenib, Sunitinib, Pemetrexed, Docetaxel, and Paclitaxel.

Cardiovascular medications, such as Amlodipine, Atorvastatin, Rosuvastatin, Telmisartan, Ramipril, and Metoprolol.

Neurology products, including Levetiracetam, Gabapentin, Pregabalin, and Donepezil.

Gastroenterology drugs, such as Pantoprazole, Rabeprazole, Omeprazole, and Domperidone.

Pain management and Anti-inflammatory products, like Paracetamol, Ibuprofen, Diclofenac, and Etoricoxib.

Anti-diabetics, including Metformin, Glimepiride, Sitagliptin, and Vildagliptin.

Anti-infectives, such as Cefixime, Azithromycin, Levofloxacin, and Moxifloxacin.

Respiratory medications, including Montelukast and Salbutamol.

Dermatology products, comprising various topical creams and ointments.

Urology products, such as Tamsulosin.

Biosimilars, including Filgrastim, Pegfilgrastim, Rituximab, Trastuzumab, and Adalimumab.

They also produce a broad array of other generic medicines for diverse therapeutic indications.